Works by Posgai, Amanda L.


Results: 36
    1
    2
    3
    4
    5
    6

    De‐coding genetic risk variants in type 1 diabetes.

    Published in:
    Immunology & Cell Biology, 2021, v. 99, n. 5, p. 496, doi. 10.1111/imcb.12438
    By:
    • Shapiro, Melanie R;
    • Thirawatananond, Puchong;
    • Peters, Leeana;
    • Sharp, Robert C;
    • Ogundare, Similoluwa;
    • Posgai, Amanda L;
    • Perry, Daniel J;
    • Brusko, Todd M
    Publication type:
    Article
    7

    Guidelines for standardizing T‐cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes.

    Published in:
    European Journal of Immunology, 2022, v. 52, n. 3, p. 372, doi. 10.1002/eji.202049067
    By:
    • Yang, Jennie H. M.;
    • Ward‐Hartstonge, Kirsten A.;
    • Perry, Daniel J.;
    • Blanchfield, J. Lori;
    • Posgai, Amanda L.;
    • Wiedeman, Alice E.;
    • Diggins, Kirsten;
    • Rahman, Adeeb;
    • Tree, Timothy I. M.;
    • Brusko, Todd M.;
    • Levings, Megan K.;
    • James, Eddie A.;
    • Kent, Sally C.;
    • Speake, Cate;
    • Homann, Dirk;
    • Long, S. Alice
    Publication type:
    Article
    8
    9
    10
    11

    The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium.

    Published in:
    Diabetologia, 2025, v. 68, n. 1, p. 186, doi. 10.1007/s00125-024-06298-y
    By:
    • Hanna, Stephanie J.;
    • Bonami, Rachel H.;
    • Corrie, Brian;
    • Westley, Monica;
    • Posgai, Amanda L.;
    • Luning Prak, Eline T.;
    • Breden, Felix;
    • Michels, Aaron W.;
    • Brusko, Todd M.;
    • Baschal, Erin;
    • Cerosaletti, Karen;
    • Corrie, Lorissa;
    • Gomez-Tourino, Iria;
    • Higdon, Lauren;
    • Kent, Sally C.;
    • Linsley, Peter;
    • Nakayama, Maki;
    • Neller, Kira;
    • Ruff, William E.;
    • Teyton, Luc
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.

    Published in:
    2016
    By:
    • Haller, Michael J.;
    • Gitelman, Stephen E.;
    • Gottlieb, Peter A.;
    • Michels, Aaron W.;
    • Perry, Daniel J.;
    • Schultz, Andrew R.;
    • Hulme, Maigan A.;
    • Shuster, Jonathan J.;
    • Baiming Zou;
    • Wasserfall, Clive H.;
    • Posgai, Amanda L.;
    • Mathews, Clayton E.;
    • Brusko, Todd M.;
    • Atkinson, Mark A.;
    • Schatz, Desmond A.;
    • Zou, Baiming
    Publication type:
    journal article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.

    Published in:
    Diabetes, 2021, v. 70, n. 5, p. 1123, doi. 10.2337/db20-1103
    By:
    • Lin, Andrea;
    • Mack, Jasmine A.;
    • Bruggeman, Brittany;
    • Jacobsen, Laura M.;
    • Posgai, Amanda L.;
    • Wasserfall, Clive H.;
    • Brusko, Todd M.;
    • Atkinson, Mark A.;
    • Gitelman, Stephen E.;
    • Gottlieb, Peter A.;
    • Gurka, Matthew J.;
    • Mathews, Clayton E.;
    • Schatz, Desmond A.;
    • Haller, Michael J.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    A genomic data archive from the Network for Pancreatic Organ donors with Diabetes.

    Published in:
    Scientific Data, 2023, v. 10, n. 1, p. 1, doi. 10.1038/s41597-023-02244-6
    By:
    • Perry, Daniel J.;
    • Shapiro, Melanie R.;
    • Chamberlain, Sonya W.;
    • Kusmartseva, Irina;
    • Chamala, Srikar;
    • Balzano-Nogueira, Leandro;
    • Yang, Mingder;
    • Brant, Jason O.;
    • Brusko, Maigan;
    • Williams, MacKenzie D.;
    • McGrail, Kieran M.;
    • McNichols, James;
    • Peters, Leeana D.;
    • Posgai, Amanda L.;
    • Kaddis, John S.;
    • Mathews, Clayton E.;
    • Wasserfall, Clive H.;
    • Webb-Robertson, Bobbie-Jo M.;
    • Campbell-Thompson, Martha;
    • Schatz, Desmond
    Publication type:
    Article
    35
    36

    Human CD4<sup>+</sup>CD25<sup>+</sup>CD226<sup>-</sup> Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>lo/-</sup> Tregs for Adoptive Cell Therapy.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.873560
    By:
    • Brown, Matthew E.;
    • Peters, Leeana D.;
    • Hanbali, Seif R.;
    • Arnoletti, Juan M.;
    • Sachs, Lindsey K.;
    • Nguyen, Kayla Q.;
    • Carpenter, Emma B.;
    • Seay, Howard R.;
    • Fuhrman, Christopher A.;
    • Posgai, Amanda L.;
    • Shapiro, Melanie R.;
    • Brusko, Todd M.
    Publication type:
    Article